Temperature-gated ferritin-mediated brain targeting of α-asarone remodels microglia and suppresses neuroinflammation in Alzheimer’s disease

Neuroinflammation driven by dysfunctional microglia is a core pathological feature of Alzheimer’s disease (AD), yet most small-molecule therapeutics including α-asarone (α-A) fail to achieve adequate brain exposure because of the blood–brain barrier(BBB) and moreover face dose-limiting hepatotoxicity that collapses the therapeutic window. Here, we devised a temperature-gradient molecular gating strategy that drives α-A into the cavity of recombinant human heavy-chain ferritin (RhFn) without requiring 24-mer disassembly, which compromises the structural integrity and BBB transcytosis efficiency of conventional pH-loaded ferritin. The resulting nanoformulation, α-A@RhFn, exploits transferrin receptor 1 (TfR1)-mediated transcytosis to cross the BBB and deliver α-A to the brain parenchyma at pharmacologically relevant concentrations. Within the brain, α-A@RhFn shifts microglial polarization from the proinflammatory M1 phenotype toward the neuroprotective M2 state by comodulating the TREM2/TLR4 axis, which in turn attenuates neuroinflammation, reduces the amyloid-β (Aβ) burden and protects synaptic integrity. Integrative transcriptomic and metabolomic profiling further revealed that these effects are underpinned by selective activation of the Wnt pathway together with coordinated modulation of cAMP and calcium signaling, collectively reversing gene and metabolite signatures associated with neuroinflammatory and synaptic damage. These multidimensional actions establish a ferritin-based nanomedicine strategy that connects traditional Chinese medicine with precision neurotherapeutics for AD.

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-11-16
DOI
https://doi.org/10.1186/s12951-026-05256-7
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Temperature-gated ferritin-mediated brain targeting of α-asarone remodels microglia and suppresses neuroinflammation in Alzheimer’s disease

Huamao Zhou, Xiaoling Xu, Wang Z, Wen Wu et al.
5 links
Journal of Nanobiotechnology
Nanoparticle-Based Drug Delivery
article

Temperature-gated ferritin-mediated brain targeting of α-asarone remodels microglia and suppresses neuroinflammation in Alzheimer’s disease

Huamao Zhou, Xiaoling Xu, Wang Z, Wen Wu, Wei Chen, Jun Yang
article en

Abstract

Neuroinflammation driven by dysfunctional microglia is a core pathological feature of Alzheimer’s disease (AD), yet most small-molecule therapeutics including α-asarone (α-A) fail to achieve adequate brain exposure because of the blood–brain barrier(BBB) and moreover face dose-limiting hepatotoxicity that collapses the therapeutic window. Here, we devised a temperature-gradient molecular gating strategy that drives α-A into the cavity of recombinant human heavy-chain ferritin (RhFn) without requiring 24-mer disassembly, which compromises the structural integrity and BBB transcytosis efficiency of conventional pH-loaded ferritin. The resulting nanoformulation, α-A@RhFn, exploits transferrin receptor 1 (TfR1)-mediated transcytosis to cross the BBB and deliver α-A to the brain parenchyma at pharmacologically relevant concentrations. Within the brain, α-A@RhFn shifts microglial polarization from the proinflammatory M1 phenotype toward the neuroprotective M2 state by comodulating the TREM2/TLR4 axis, which in turn attenuates neuroinflammation, reduces the amyloid-β (Aβ) burden and protects synaptic integrity. Integrative transcriptomic and metabolomic profiling further revealed that these effects are underpinned by selective activation of the Wnt pathway together with coordinated modulation of cAMP and calcium signaling, collectively reversing gene and metabolite signatures associated with neuroinflammatory and synaptic damage. These multidimensional actions establish a ferritin-based nanomedicine strategy that connects traditional Chinese medicine with precision neurotherapeutics for AD.

Journal of Nanobiotechnology
Sir Run Run Shaw Hospital (CN), Zhejiang Shuren University (CN), Zhejiang University (CN), University of South China (CN)
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon